全文获取类型
收费全文 | 4675篇 |
免费 | 343篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 250篇 |
妇产科学 | 61篇 |
基础医学 | 554篇 |
口腔科学 | 113篇 |
临床医学 | 491篇 |
内科学 | 1039篇 |
皮肤病学 | 65篇 |
神经病学 | 324篇 |
特种医学 | 423篇 |
外科学 | 506篇 |
综合类 | 131篇 |
预防医学 | 341篇 |
眼科学 | 38篇 |
药学 | 412篇 |
1篇 | |
中国医学 | 6篇 |
肿瘤学 | 282篇 |
出版年
2022年 | 36篇 |
2021年 | 86篇 |
2020年 | 40篇 |
2019年 | 80篇 |
2018年 | 83篇 |
2017年 | 69篇 |
2016年 | 88篇 |
2015年 | 95篇 |
2014年 | 109篇 |
2013年 | 193篇 |
2012年 | 210篇 |
2011年 | 206篇 |
2010年 | 148篇 |
2009年 | 184篇 |
2008年 | 184篇 |
2007年 | 223篇 |
2006年 | 194篇 |
2005年 | 179篇 |
2004年 | 175篇 |
2003年 | 171篇 |
2002年 | 130篇 |
2001年 | 99篇 |
2000年 | 90篇 |
1999年 | 98篇 |
1998年 | 132篇 |
1997年 | 146篇 |
1996年 | 139篇 |
1995年 | 102篇 |
1994年 | 102篇 |
1993年 | 116篇 |
1992年 | 54篇 |
1991年 | 49篇 |
1990年 | 74篇 |
1989年 | 81篇 |
1988年 | 84篇 |
1987年 | 61篇 |
1986年 | 55篇 |
1985年 | 60篇 |
1984年 | 38篇 |
1983年 | 32篇 |
1982年 | 39篇 |
1981年 | 59篇 |
1980年 | 41篇 |
1979年 | 48篇 |
1978年 | 31篇 |
1977年 | 41篇 |
1976年 | 38篇 |
1973年 | 26篇 |
1972年 | 28篇 |
1971年 | 26篇 |
排序方式: 共有5048条查询结果,搜索用时 15 毫秒
1.
Birth weight on 12,644 singleton infants from 6,196 sibships born in Maryland between 1980 and 1984 were used to estimate the effects of nine maternal and infant covariates on the sibship correlation in birth weight. Assuming a homogeneous correlation across all families, the estimated intraclass correlation was 0.4664 (+/- 0.0099). This high sibship correlation makes it possible to predict, with reasonable accuracy, the birth weight of a child given information on previous sibs, as well as covariates on the mother and/or infant pertinent to a given pregnancy. The reduction in variance associated with incorporating information on the nine covariates used here was approximately equal to that obtained by conditioning on a single previous sib. Testing for heterogeneity in correlation among different groups of families showed that a crude measure of parity (first live birth vs. other), time between births, mother's marital status, and maternal age at the birth of the last child significantly influenced the sibship correlation in birth weight. 相似文献
2.
3.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
4.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
5.
There is growing interest in the phenomenon of long-term depression (LTD) of synaptic efficacy that, together with long-term potentiation (LTP), is a putative information storage mechanism in mammalian brain. In neural network models, multiple learning rules have been used for LTD induction. Similarly, in neurophysiological studies of hippocampal synaptic plasticity, a variety of activity patterns have been effective at inducing LTD, although experimental paradigms are still being optimized. In this review the authors summarize the major experimental paradigms and compare what is known about the mechanisms of LTD induction. Although all paradigms appear to initiate a cascade of events leading to an elevated level of Ca2+ postsynaptically, the extent to which these paradigms involve common expression mechanisms has not yet been tested. The authors discuss several critical experiments that would address this latter issue. Numerous questions about the properties and mechanisms of LTD(s) in the hippocampus remain to be answered, but it is clear that LTD has finally arrived, and will soon be attracting attention equal to its flip side, LTP. © 1994 Wiley-Liss, Inc. 相似文献
6.
7.
Christie AB 《Postgraduate medical journal》1949,25(287):409-412
8.
Summary Patients with insulin-dependent diabetes mellitus (IDDM) possess antibodies to the cytoplasmic domains of two closely related
tyrosine phosphatase-like proteins, IA-2 and phogrin, previously detected as 40 kDa and 37 kDa tryptic fragments, respectively.
A higher proportion of IDDM patients possess antibodies to IA-2 than to phogrin, and autoimmunity to phogrin might arise through
cross-reactivity with the highly homologous IA-2. In this study, we have investigated the major regions of IA-2 recognized
by antibodies in IDDM patients and examined the ability of phogrin to block antibody binding to these regions as a measure
of cross-reactivity. Analysis of antibody binding to in vitro transcribed and translated polypeptides representing different
regions of the cytoplasmic domain of IA-2 identified five different patterns of reactivity with antibodies in IDDM. Protein
footprinting analysis, whereby polypeptide fragments generated on protease treatment of immune complexes are studied, indicated
considerable heterogeneity in antibody recognition of IA-2, even between sera with similar reactivity to deletion mutants.
Blocking studies with recombinant phogrin indicated that IA-2 antibodies recognize epitopes that are both unique to IA-2 and
shared with phogrin. The amino-terminal 150 amino acids of the cytoplasmic domain of IA-2 encompass epitopes that are not
represented on phogrin, whereas shared epitopes are localized within the carboxy-terminal 220 amino acids. The results demonstrate
considerable heterogeneity between IDDM patients in autoantibody recognition of IA-2 in IDDM, whereas antibody recognition
of phogrin is restricted in most patients to epitopes also present on IA-2. [Diabetologia (1997) 40: 1327–1333]
Received: 4 April 1997 and in revised form: 2 July 1997 相似文献
9.
10.
C M Court-Brown J Christie M M McQueen 《The Journal of bone and joint surgery. British volume》1990,72(4):605-611
We present the results of using the Grosse-Kempf interlocking nail in the management of 125 closed and type I open tibial fractures. The mean time to union was 16.7 weeks and no fracture required bone grafting. Mobilisation of the patient and the range of joint movement were better than with other methods of treating tibial fractures. There was a 1.6% incidence of infection; 40.8% of patients had knee pain and 26.4% needed to have the nail removed. Other complaints were minor. We suggest that closed intramedullary nailing with an interlocking nail system is an excellent method of treating closed and type I open tibial fractures. 相似文献